Retatrutide vs Tirzepatide
Triple agonist vs dual agonist — receptor profile and research framing.
Compare →Educational resources, laboratory quality information, side-by-side comparisons, certificates of analysis and answers to common research questions — written for UK laboratories.
A laboratory overview of retatrutide (LY3437943) — a triple agonist research peptide acting on the GLP-1, GIP and glucagon receptors.
Read guide →Background on retatrutide in the academic literature — receptor pharmacology, study context and analytical handling.
Read guide →Side-by-side comparison of retatrutide and tirzepatide across receptor profile, research context and analytical considerations.
Read guide →Triple agonist vs dual agonist — receptor profile and research framing.
Compare →Triple incretin agonism compared to a single GLP-1 agonist.
Compare →How combined receptor activity differs from dual-incretin compounds.
Compare →A permanent research library covering retatrutide, GLP-1 peptides, COAs, purity testing and laboratory handling — written for UK researchers.
Guides summarise published research and our own analytical standards. References are provided where relevant; original literature should always be consulted for primary data.
Guides are reviewed and dated. New guides are added as new compounds, methods or COAs are introduced.
No. All compounds supplied by BuyRetaUK are strictly for in-vitro laboratory research use only.
Every batch ships with a COA. The full library is available on the verification page.